Derma Sciences Inc (DSCI.OQ) Key Developments | Reuters.com
Edition:
United States

Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

3.77USD
27 Jun 2016
Change (% chg)

-- (--)
Prev Close
$3.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,475
52-wk High
$7.35
52-wk Low
$2.85

Latest Key Developments (Source: Significant Developments)

Derma Sciences Inc gives FY 2016 net sales guidance
Thursday, 7 Jan 2016 07:30am EST 

Derma Sciences Inc:Expects FY 2016 net sales to be about $89.1 million, representing growth of 5.4% compared with preliminary FY 2015 net sales of $84.5 million.  Full Article

Derma Sciences, Inc announces leadership and CEO Transition
Monday, 21 Dec 2015 07:30am EST 

Derma Sciences, Inc:Announces leadership and CEO transition.Stephen T. Wills Unanimously appointed by board to serve as interim executive chairman and principal executive officer.Edward J. Quilty will depart from position of chief executive officer and chairman.Special committee of the board will immediately begin the search for a permanent CEO with the assistance of korn ferry.  Full Article

Derma Sciences Inc affirms FY 2015 net sales guidance
Monday, 9 Nov 2015 07:30am EST 

Derma Sciences Inc:Affirms its previous financial guidance for FY 2015 net sales to be about $88.1 million.  Full Article

Derma Sciences Inc affirms FY 2015 sales guidance
Monday, 10 Aug 2015 07:30am EDT 

Derma Sciences Inc:Says that it affirms previous guidance for FY 2015.Sees FY 2015 net sales to be about $88.1 million, representing growth of 5 pct. compared with FY 2014 net sales.  Full Article

Derma Sciences Inc Provides Update on Aclerastide Phase 3 Trials
Tuesday, 19 May 2015 07:30am EDT 

Derma Sciences Inc:Says taking steps toward accelerating screening, enrollment by opening additional sites in eastern europe, germany and potentially israel.Says has targeted the end of june 2016 for the last subject to be randomized in the pivotal program.Says expect to enroll the first subject from these new sites in september.  Full Article

Derma Sciences Inc reaffirms FY 2015 net sales guidance
Monday, 11 May 2015 07:00am EDT 

Derma Sciences Inc:Affirms FY 2015 guidance provided in March for 2015.Sees FY 2015 net sales to be about $88.1 million.  Full Article

Derma Sciences Inc reaffirms FY 2015 revenue guidance
Thursday, 12 Mar 2015 07:30am EDT 

Derma Sciences Inc:Affirms the financial guidance provided in Jan. for FY 2015 net sales to be about $88.1 million.FY 2015 revenue of $88.4 million - Thomson Reuters I/B/E/S.  Full Article

Derma Sciences Inc gives FY 2015 revenue guidance below analysts' estimates
Thursday, 8 Jan 2015 07:30am EST 

Derma Sciences Inc:Expects FY 2015 net sales to be about $88.1 million.FY 2015 revenue of $93.5 million - Thomson Reuters I/B/E/S.  Full Article

Derma Sciences Inc lowers FY 2014 revenue guidance
Monday, 10 Nov 2014 07:30am EST 

Derma Sciences Inc:Expects FY 2014 net sales to be about $85.0 million.Says that this compares with previous guidance for net sales to be about $86.0 million.FY 2014 revenue of $85.5 million - Thomson Reuters I/B/E/S.  Full Article

Derma Sciences Inc lowers FY 2014 revenue guidance below analysts' estimates
Thursday, 7 Aug 2014 07:30am EDT 

Derma Sciences Inc:Expects FY 2014 net sales to be about $86.0 million.FY 2014 revenue of $91 million - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Derma Sciences Q1 loss per share $0.07 from continuing operations

* "quarterly sales will be impacted by ordering patterns and by delivery dates, particularly in twc business"